Booth Andrew's Form 4 filing
AbCellera Biologics Inc. (ABCL) · filed Nov 15, 2021
- Accession no.
- 0001209191-21-064378
- Filed
- Nov 15, 2021
- Trade date
- Nov 11, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $993.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Booth AndrewCIK 0001834411 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Common Shares | PPurchaseAcquired | +53,500 | $14.74 | +$788,590 | 53,500 | Direct | |
| Nov 11, 2021 | Common Shares | PPurchaseAcquired | +14,000 | $14.61 | +$204,540 | 130,959 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.